US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Nutra Pharma Provides Sales and Marketing Update

Nutra Pharma is providing an update on the sales and marketing efforts of TCN as they begin their global marketing campaign for Nutra Pharma's over-the-counter (OTC) pain reliever, Nyloxin™.Coral Springs, FL. – December 20, 2012 - Nutra Pharma Corp. (OTCQB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), is providing updates on the sales and marketing activities of TCN, a distributor of Nutra Pharma's over-the-counter (OTC) pain reliever, Nyloxin™ . In September 2012, Nutra Pharma

Nutra Pharma Introduces Nyloxin™ Military Strength

Nutra Pharma is introducing a stronger version of its over-the-counter (OTC) pain reliever, Nyloxin™, and has begun the process of registration with the United States government for sales into the military.Coral Springs, FL. – December 19, 2012 - Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it will be introducing a stronger version of its over-the-counter (OTC) pain reliever, Nyloxin™ . The new product will be called Nyloxin™ Military

Nutra Pharma Letter to Shareholders

Nutra Pharma CEO, Rik J Deitsch, has published a letter to Shareholders outlining the current efforts and the future goals of the CompanyDecember 18, 2012 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the Company's Chief Executive Officer, Rik J Deitsch, had published a Shareholder Letter on the Company's website. “We have been very busy here at Nutra Pharma,” explained Rik J Deitsch,

Nutra Pharma Begins Marketing Nyloxin™ Through Direct Distributors

Nutra Pharma announces the direct distribution of their Nyloxin™ line of pain relievers through TCN, a network of distributors in more than 20 countries.September 20, 2012 -- Coral Springs, Florida -- Nutra Pharma Corporation (Pink Sheets: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that they have begun selling Nyloxin through the TCN group of direct distributors. “We are excited to be working with TCN to aggressively market and sell Nyloxin,” explained

Nutra Pharma Begins Affiliate Sales & Marketing Program for the Distribution of Nyloxin™

Nutra Pharma announces the roll-out of a two-level, on-line affiliate sales and marketing plan for the sales and distribution of their Nyloxin™ line of pain relievers.May 2, 2012 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that LWR Partners, their outside branding and marketing firm, has begun their on-line affiliate sales and marketing program to aid in the promotion, branding and distribution

There are no items matching the current filter
There are no more items matching the current filter
Back to top